Inventor
ZENON D. KONTEATIS
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds29%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium10%
C07BGeneral methods of organic chemistry5%
PatentTitleYear
12,433,895Therapeutically active compounds and their methods of use202512,077,534Aza-heterobicyclic inhibitors of MAT2A and methods of use for treating cancer2024RE049934Inhibitors of cellular metabolic processes202411,919,915Compounds and methods useful for stabilizing phenylalanine hydroxylase mutations202411,524,960Heterobicyclic inhibitors of MAT2A and methods of use for treating cancer202211,325,914Inhibitors of cellular metabolic processes2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to SERVIER PHARMACEUTICALS LLC (4)· patent assignee history
2022–2024Patents assigned to AGIOS PHARMACEUTICALS INC (3)· patent assignee history
2022–2025Based in US· patent location history
2024Patents assigned to LES LABORATOIRES SERVIER SAS (1)· patent assignee history
2024Patents assigned to SERVIER LAB (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SERVIER PHARMACEUTICALS LLC | 4 | 2022–2025 |
| AGIOS PHARMACEUTICALS INC | 3 | 2022–2024 |
| LES LABORATOIRES SERVIER SAS | 1 | 2024 |
| SERVIER LAB | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2022–2025 |